Global Biotechnology Company

Global Biotechnology Company Standardizes International Cash Management with Redbridge

Challenge

A biotechnology provider with operations across 31 countries and six banking partners needed to bring structure, consistency, and control to its international cash management practices. With diverse pricing models, inconsistent service terms, and fragmented banking relationships, the client faced inefficiencies in managing costs and aligning its treasury operations with evolving global needs.

Solution

Redbridge performed a thorough review of the client’s international cash management framework, evaluating banking relationships, service utilization, and associated fees across all regions. A multi-country audit of historical banking data enabled Redbridge to identify opportunities for harmonization and optimization.

By aligning pricing structures and standardizing contract terms across all primary banks, the client established a consistent foundation for cost management and service delivery, while maintaining the flexibility required for future growth. Redbridge supported the client throughout the process, including in negotiations, and will continue to provide ongoing fee monitoring over a multi-year period.

Results

The engagement delivered clear improvements in efficiency, consistency, and transparency:

• Standardized pricing implemented across all core international banking partners for a 3-year term
• Redundant services identified and eliminated, improving both cost efficiency and operational focus
• Ongoing fee monitoring ensures that agreed pricing structures remain intact over time
• Improved visibility and governance across a complex, multi-region treasury environment